Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[NOS1AP Gene Polymorphism and Body Fat in Patients with Schizophrenia: A Search for Associations].

Molekuliarnaia biologiia - 1 Jan 2025

Tiguntsev V V, Mednova I A, Petkun D A, Agarkov A A, Kornetov A N, Pozhidaev I V, Paderina D Z, Kornetova E G, Ivanova S A

Abstract excerpt

Long-term pharmacotherapy in patients with schizophrenia can provoke antipsychotic-induced obesity. This side effect does not always meet the criteria for metabolic syndrome (MS), primarily central obesity. However, this significantly reduces the quality of life of patients and is a risk factor for the development of many diseases. In humans, the NOS1AP gene product is involved in adipogenesis, dendrite...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adaptor Proteins, Signal Transducing
Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Intra-Abdominal Fat

Share to Metabolic Syndrome

Share to Polymorphism, Single Nucleotide

Share to Schizophrenia

Source

Identifiers

PMID: 40542634
DOI: 10.31857/S0026898425010073

Genes

NOS1AP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[NOS1AP Gene Polymorphism and Body Fat in Patients with Schizophrenia: A Search for Associations].PMID 40542634Read ↗

NOS1AP Gene Variants and Their Role in Metabolic Syndrome: A Study of Patients with SchizophreniaSemantic proximity Read ↗

A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.Semantic proximity Read ↗

CNR1 gene and risk of the metabolic syndrome in patients with schizophrenia.Semantic proximity Read ↗

Gender differences in the effects of peroxisome proliferator-activated receptor γ2 gene polymorphisms on metabolic adversity in patients with schizophrenia or schizoaffective disorder.Semantic proximity Read ↗

NOS1AP in schizophrenia.Semantic proximity Read ↗

Schizophrenia and cardiometabolic abnormalities: A Mendelian randomization studySemantic proximity Read ↗

Association Between NOS1 Gene Polymorphisms and Schizophrenia in Asian and Caucasian Populations: A Meta-Analysis.Semantic proximity Read ↗

Association of NOS1AP variants and depression phenotypes in schizophrenia.Semantic proximity Read ↗

Association of FTO, LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics.Semantic proximity Read ↗

Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders.Semantic proximity Read ↗

Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs.Semantic proximity Read ↗

Prevalence and factors associated of metabolic syndrome in first- treatment drug-naïve schizophrenia patients: a large-scale cross- sectional studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.